Embedded Files
5. The CADD Workflow (Step-by-Step for Beginners)
A typical CADD project follows a structured workflow:
A typical CADD project follows a structured workflow:
1. Target Identification & Validation: The first step involves identifying a biological target (e.g., a specific protein) that plays a critical role in a disease pathway. This target is then validated to ensure it is "druggable" and that modulating its activity can lead to a therapeutic benefit.
1. Target Identification & Validation: The first step involves identifying a biological target (e.g., a specific protein) that plays a critical role in a disease pathway. This target is then validated to ensure it is "druggable" and that modulating its activity can lead to a therapeutic benefit.
2. Target Structure Acquisition: If pursuing Structure-Based Drug Design, the 3D atomic structure of the identified target needs to be obtained. This is ideally done experimentally (X-ray, Cryo-EM, NMR) or, if necessary, through computational modeling (e.g., homology modeling).
2. Target Structure Acquisition: If pursuing Structure-Based Drug Design, the 3D atomic structure of the identified target needs to be obtained. This is ideally done experimentally (X-ray, Cryo-EM, NMR) or, if necessary, through computational modeling (e.g., homology modeling).
3. Ligand Preparation: Potential drug molecules (ligands) from large databases are prepared for computational analysis. This involves optimizing their 3D structures, correcting charges, adding missing atoms (like hydrogens), and ensuring they are in a suitable format for the chosen CADD software.
3. Ligand Preparation: Potential drug molecules (ligands) from large databases are prepared for computational analysis. This involves optimizing their 3D structures, correcting charges, adding missing atoms (like hydrogens), and ensuring they are in a suitable format for the chosen CADD software.
4. Virtual Screening (Docking or Ligand-Based): This is the core computational screening step. Using either molecular docking (for SBDD) or ligand-based approaches (like pharmacophore screening or QSAR prediction), thousands to millions of compounds are computationally evaluated to identify initial "hits" – compounds that show promise.
4. Virtual Screening (Docking or Ligand-Based): This is the core computational screening step. Using either molecular docking (for SBDD) or ligand-based approaches (like pharmacophore screening or QSAR prediction), thousands to millions of compounds are computationally evaluated to identify initial "hits" – compounds that show promise.
5. Hit to Lead: The identified "hits" are then carefully evaluated and prioritized. This involves assessing their predicted binding affinity, considering their ADME (Absorption, Distribution, Metabolism, Excretion) properties (which describe how a drug behaves in the body), and evaluating potential toxicity. The most promising hits are selected as "leads."
5. Hit to Lead: The identified "hits" are then carefully evaluated and prioritized. This involves assessing their predicted binding affinity, considering their ADME (Absorption, Distribution, Metabolism, Excretion) properties (which describe how a drug behaves in the body), and evaluating potential toxicity. The most promising hits are selected as "leads."
6. Lead Optimization: The initial lead compounds are further modified and improved using CADD techniques. The goal is to enhance their potency, improve selectivity, reduce off-target effects, and optimize other drug-like properties.
6. Lead Optimization: The initial lead compounds are further modified and improved using CADD techniques. The goal is to enhance their potency, improve selectivity, reduce off-target effects, and optimize other drug-like properties.
7. Preclinical Testing: Once optimized, the most promising lead compounds transition to experimental testing in the laboratory. This includes in vitro (cell-based or biochemical assays) and *in vivo (animal model) studies to validate their efficacy, safety, and pharmacokinetics.
7. Preclinical Testing: Once optimized, the most promising lead compounds transition to experimental testing in the laboratory. This includes in vitro (cell-based or biochemical assays) and *in vivo (animal model) studies to validate their efficacy, safety, and pharmacokinetics.
8. Clinical Trials: (While beyond the direct scope of CADD, it's the critical next stage.) If preclinical tests are successful, the drug candidate proceeds to human clinical trials, a rigorous, multi-phase process that assesses safety and efficacy in humans.
8. Clinical Trials: (While beyond the direct scope of CADD, it's the critical next stage.) If preclinical tests are successful, the drug candidate proceeds to human clinical trials, a rigorous, multi-phase process that assesses safety and efficacy in humans.
6. Limitations and Challenges of CADD While incredibly powerful, it's crucial to acknowledge the limitations of CADD:
6. Limitations and Challenges of CADD While incredibly powerful, it's crucial to acknowledge the limitations of CADD:
Accuracy of Predictions: CADD provides predictions and guidance, not absolute guarantees. Experimental validation in the wet lab is always essential to confirm computational findings.
Simplifications: Computational models inherently simplify complex biological systems. It's challenging to capture every subtle nuance of biological reality.
Computational Resources: Some advanced simulations, particularly long molecular dynamics runs or screening vast libraries, require significant computational power and specialized hardware.
Data Quality: The reliability of CADD results heavily depends on the quality of the input data, including the accuracy of target protein structures and experimental activity data for ligands. The principle of "Garbage in, garbage out" applies here.
Flexibility of Molecules: Accurately accounting for the significant flexibility and conformational changes of both the target protein and the ligand during binding remains a complex challenge.
🧠 🔬 Getting Started with CADD (Practical Advice for Beginners) If you're excited to dive deeper into CADD, here's some advice to get you started🥰🤩🥰:
🧠 🔬 Getting Started with CADD (Practical Advice for Beginners) If you're excited to dive deeper into CADD, here's some advice to get you started🥰🤩🥰:
Learn the Basics of Chemistry and Biology: A solid foundational understanding of organic chemistry, biochemistry, and molecular biology is essential for truly grasping concepts in CADD.
Learn the Basics of Chemistry and Biology: A solid foundational understanding of organic chemistry, biochemistry, and molecular biology is essential for truly grasping concepts in CADD.
Explore Free Software: Download and experiment with the free molecular visualization tools mentioned above (PyMOL, Chimera). Get comfortable viewing and manipulating 3D molecular structures.
Explore Free Software: Download and experiment with the free molecular visualization tools mentioned above (PyMOL, Chimera). Get comfortable viewing and manipulating 3D molecular structures.
Online Tutorials and Courses: Take advantage of the many excellent free and paid online resources. Look for tutorials on YouTube, massive open online courses (MOOCs) from platforms like Coursera and edX, and resources provided by academic institutions.
Online Tutorials and Courses: Take advantage of the many excellent free and paid online resources. Look for tutorials on YouTube, massive open online courses (MOOCs) from platforms like Coursera and edX, and resources provided by academic institutions.
Practice, Practice, Practice: Like any scientific skill, CADD requires hands-on experience. Try to follow along with tutorials, replicate simple docking experiments, and explore different molecular structures. The more you practice, the more intuitive the concepts will become.
Practice, Practice, Practice: Like any scientific skill, CADD requires hands-on experience. Try to follow along with tutorials, replicate simple docking experiments, and explore different molecular structures. The more you practice, the more intuitive the concepts will become.
REFERENCES
REFERENCES
Bassani, D., & Moro, S. (2023). Past, present, and future perspectives on Computer-Aided Drug Design Methodologies. Molecules, 28(9), 3906. https://doi.org/10.3390/molecules28093906.
Bassani, D., & Moro, S. (2023). Past, present, and future perspectives on Computer-Aided Drug Design Methodologies. Molecules, 28(9), 3906. https://doi.org/10.3390/molecules28093906.
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015). Role of computer-aided drug design in modern drug discovery. Archives of Pharmacal Research, 38(9), 1686–1701. https://doi.org/10.1007/s12272-015-0640-5
Niazi, S. K., & Mariam, Z. (2023). Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis. Preprints (www.preprints.org).https://doi.org/10.20944/preprints202311.0852.v1.
Niazi, S. K., & Mariam, Z. (2023). Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis. Preprints (www.preprints.org).https://doi.org/10.20944/preprints202311.0852.v1.
Niazi, S. K., & Mariam, Z. (2023b). Computer-Aided Drug Design and Drug Discovery: A Prospective analysis. Pharmaceuticals, 17(1), 22. https://doi.org/10.3390/ph17010022.
Ouma, R. B. O., Ngari, S. M., & Kibet, J. K. (2024). A review of the current trends in computational approaches in drug design and metabolism. Deleted Journal, 21(1). https://doi.org/10.1186/s12982-024-00229-3.
Padole, N. S. S., Asnani, N. a. J., Chaple, N. D. R., & Katre, N. S. G. (2022). A review of approaches in computer-aided drug design in drug discovery. GSC Biological and Pharmaceutical Sciences, 19(2), 075–083. https://doi.org/10.30574/gscbps.2022.19.2.0161.
Prasad, S., Srivastava, A., Singh, N., Singh, H., Saluja, R., Kumar, A., Yadav, N., & Qidwai, T. (2022). Present and future challenges in therapeutic designing using computational approaches. In Elsevier eBooks (pp. 489–505). https://doi.org/10.1016/b978-0-323-91172-6.00020-0
Pei, Z. (2024). Computer-aided drug discovery: From traditional simulation methods to language models and quantum computing. Cell Reports Physical Science, 102334. https://doi.org/10.1016/j.xcrp.2024.102334.
Rajkishan, T., Rachana, A., Shruti, S., Bhumi, P., & Patel, D. (2021). Computer-Aided Drug Designing. In Advances in Bioinformatics (pp. 151–182). https://doi.org/10.1007/978-981-33-6191-1_9.
Strømgaard, K., Krogsgaard-Larsen, P., & Madsen, U. (2022). Textbook of Drug Design and Discovery. CRC Press.
Vemula, D., Jayasurya, P., Sushmitha, V., Kumar, Y. N., & Bhandari, V. (2022). CADD, AI, and ML in drug discovery: A comprehensive review. European Journal of Pharmaceutical Sciences, 181, 106324. https://doi.org/10.1016/j.ejps.2022.106324
Yu, W., & MacKerell, A. D. (2016). Computer-Aided Drug Design Methods. Methods in Molecular Biology, 85–106. https://doi.org/10.1007/978-1-4939-6634-9_5.
We hope this tutorial provides you with a solid foundation in Computer-Aided Drug Design. Keep exploring—this field evolves quickly, and your curiosity is the most powerful tool! 🗣️
Page updated
Google Sites
Report abuse